Articles related to MEN'S HEALTH
BCR Endpoints an Unreliable Surrogate for Survival in Prostate Cancer Trials
This study challenges the conventional reliance on BCR as a primary end point in prostate cancer trials, emphasizing the need for a more comprehensive approach that includes overall survival rates.
Oncology, Medical September 11th 2023
Factors Associated with Circulating Sex Hormones in Men
This meta-analysis provides a comprehensive look at the factors affecting testosterone levels in men, highlighting the importance of considering age, lifestyle, and health conditions for accurate diagnosis.
Endocrinology, Diabetes, Metabolism September 7th 2023
Prostate Cancer Survival Differs by Site of Visceral Metastases
New research reveals significant differences in overall survival rates based on the site of visceral metastases in metastatic prostate cancer. Discover how these insights could shape your approach to patient care.
Oncology, Radiation September 5th 2023
More Highlights in Prostate Cancer From the 2023 American Society of Clinical Oncology Annual Meeting
The ASCO 2023 meeting has unveiled key studies in prostate cancer, including insights into PSA levels post-radiation therapy, the role of BRCA mutations, and promising combination therapies.
Oncology, Medical August 21st 2023
Olaparib Plus Abiraterone and Prednisone Granted FDA Approval for BRCA-Mutated Prostate Cancer
The FDA’s approval of the olaparib, abiraterone, and prednisone regimen for BRCA-mutated mCRPC, based on the PROpel trial, could significantly alter the treatment landscape. Learn more about this promising development in prostate cancer therapy.
Oncology, Medical August 7th 2023
Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer
This study urges a re-evaluation of surrogate endpoints in advanced prostate cancer, questioning the validity of commonly used markers and calling for further research in predicting overall survival.
Oncology, Medical July 18th 2023